Age-specific Clinical Presentation and Risk Factors for Extrapulmonary Tuberculosis Disease in Children

Melanie M Dubois1,2, Meredith B Brooks2, Amyn A Malik3,4

  • 1From the Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts.

Insights

Extrapulmonary tuberculosis (EPTB) in children presents variably, often delaying diagnosis. This study in Pakistan identified age-specific risk factors like weight loss for EPTB, aiding timely diagnosis and improved outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Extrapulmonary tuberculosis (EPTB) in children often presents with nonspecific symptoms, leading to diagnostic delays and adverse outcomes.
  • Timely diagnosis of EPTB in pediatric populations is crucial for effective management and improved prognosis.

Purpose of the Study:

  • To describe the age-specific clinical presentation of extrapulmonary tuberculosis (EPTB) in children.
  • To identify risk factors associated with EPTB in different pediatric age groups in Pakistan.

Main Methods:

  • A cross-sectional study was conducted in four facilities in Sindh, Pakistan, between 2015-2016.
  • Children diagnosed with TB were assessed for EPTB based on bacteriologic confirmation or clinical-radiologic criteria, excluding pulmonary TB.
  • Age-specific regression analyses were performed to identify factors associated with EPTB in children aged 0-4, 5-9, and 10-14 years.

Main Results:

  • Out of 1163 children with TB, 157 (13.5%) had EPTB, with the most common sites being lymph nodes (72.4%) and abdomen (19.9%).
  • Weight loss was a significant risk factor for EPTB in children aged 0-4 years (aOR: 2.80) and 10-14 years (aOR: 2.79).
  • The presence of cough was associated with a decreased risk of EPTB.

Conclusions:

  • This study provides valuable insights into the age-specific clinical manifestations and risk factors of EPTB in Pakistani children.
  • The findings can inform the development of optimized clinical algorithms for earlier EPTB diagnosis in children.
  • Improved diagnostic strategies are expected to lead to better treatment outcomes for pediatric EPTB.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
337
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
468
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
214
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
424
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
251